David Jin insider trades

Open-market stock purchases and sales by David Jin, Chief Financial Officer at Fortress Biotech, Inc, from SEC Form 4 filings since Feb 20, 2020.

Track record: 33% of 3 scored buys are up 5% or more since purchase, averaging +63%.

Recent trades

DateStockTradeValue
Oct 1, 2026FBIO Fortress Biotech, IncBought (not open market)$2.2K
Jun 22, 2026FBIO Fortress Biotech, IncBought (not open market)—
Apr 1, 2026FBIO Fortress Biotech, IncBought (not open market)$6.5K
Dec 30, 2025MBIO Mustang BIO, IncBought$238

Companies traded

  • FBIO Fortress Biotech, Inc: 3 buys, last Oct 1, 2026
  • MBIO Mustang BIO, Inc: 1 buy, last Dec 30, 2025
  • ATXI Avenue Therapeutics, Inc: other filings, last Sep 23, 2024
  • AVCO Avalon GloboCare Corp: other filings, last Feb 20, 2020

Get free alerts when David Jin files a new trade →